Phase 3 Study With Ciprofloxacin Dispersion for Inhalation in Non-CF Bronchiectasis (ORBIT-3)

Completed · Phase 3 · Has a placebo group

Conditions studied: Non Cystic Fibrosis Bronchiectasis

In brief

This study (ARD-3150-1201, ORBIT-3) will evaluate the safety and efficacy of inhaled Pulmaquin (ciprofloxacin dispersion for inhalation) compared to inhaled placebo in subjects who have a confirmed diagnosis of non-cystic fibrosis (non-CF) bronchiectasis with a history of pulmonary exacerbations and chronic P. aeruginosa infections.

Key facts

Study ID

NCT01515007

Run by

Aradigm Corporation

People needed

278

Starts

2014-03-31

Expected to finish

2016-10-01

Last updated by the study team

2021-03-26

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Verified bronchiectasis diagnosis
• Pseudomonas aeruginosa lung infection

You may not qualify if…

• Cystic Fibrosis

Where it is running

• Study site — Phoenix, Arizona, United States
• Study site — Downey, California, United States
• Study site — Los Angeles, California, United States
• Study site — Poway, California, United States
• Study site — Farmington, Connecticut, United States
• Study site — Washington D.C., District of Columbia, United States
• Study site — Celebration, Florida, United States
• Study site — Kissimmee, Florida, United States
• Study site — Miami, Florida, United States
• Study site — Sebring, Florida, United States
• Study site — Kailua, Hawaii, United States
• Study site — Chicago, Illinois, United States
• Study site — Columbia, Maryland, United States
• Study site — Royal Oak, Michigan, United States
• Study site — Rochester, Minnesota, United States
• Study site — Lincoln, Nebraska, United States
• Study site — Cedar Knolls, New Jersey, United States
• Study site — New Hyde Park, New York, United States
• Study site — New York, New York, United States
• Study site — Syracuse, New York, United States
• Study site — Charlotte, North Carolina, United States
• Study site — Huntersville, North Carolina, United States
• Study site — Oklahoma City, Oklahoma, United States
• Study site — Anderson, South Carolina, United States
• Study site — Peoria, Arizona, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.